RxDoctor Payments Data

Tiffany Hoh

Podiatrist · Baltimore, MDNPI 1154764207

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Smith+Nephew at 55.1% of the total. 2025 is the largest year on record at $6,398, 4.7 times the $1,354 reported in 2019. Among podiatrist clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,732in general payments, 2019–2025

Across 189 payments — averaging $88.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$9K
  • Stryker$3K
  • Supreme Orthopedic Systems, LLC$1K
  • Integra Lifesciences Corporation$1K
  • Paragon 28, Inc.$305
  • Medline Industries LP$165
  • plus $1K from 21 others

What the payments were for

  • Consulting fees$4,50027%
  • Travel & lodging$2,21613%
  • Food & beverage$8,78953%
  • Education$1,2277%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,732 in reported general payments places this provider in the 95th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$312,037
Medicare patients
310
Services billed
2,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate47$1,168
Doxycycline Monohydrate12$85
Cephalexin30$82
Tramadol Hcl14$16

Paid to pharmacies, not to this prescriber.

Other podiatrist in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →